Chikungunya fever
Bartholomeeusen, Koen, Matthieu Daniel, Desiree A. LaBeaud, Philippe Gasque, Rosanna W. Peeling, Kathryn E. Stephenson, Lisa F. P. Ng, and Kevin K. Arien. 2023. “Chikungunya Fever”. Nature Review Disease Primers 9 (1): 17.
Search
Search results
27 results found
Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop
Yu, Xiaoying, Judith D. Lobo, Erin Sundermann-, -Kathryn E. Stephenson-, -Joseph B. Margolick, and Kristine M. Erlandson. 2023. “Current Challenges and Solutions for Clinical Management and Care of People With HIV: Findings from the 12th Annual International HIV and Aging Workshop.”
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Marcelin, Jasmine R., Audrey Pettifor, Holly Janes, Elizabeth R. Brown, James G. Kublin, and Kathryn E. Stephenson. 2022. “COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective.”
Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investmen
Ojikutu, Bisola O., Kathryn E. Stephenson, Kenneth H. Mayer, and Karen M. Emmons. 2021. “Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investmen”. American Journal of Public Health 111 (3): 366-68.
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)
Stephenson, Kathryn E., Frank Wegmann, Frank Tomaka-, -Hanneke Schuitemaker, and Dan H. Barouch. 2020. “Comparison of Shortened Mosaic HIV-1 Vaccine Schedules: A Randomised, Double-Blind, Placebo-Controlled Phase 1 Trial (IPCAVD010/HPX1002) and a Preclinical Study in Rhesus Monkeys (NHP 17-22)”. Lancet HIV 7 (6): e410-e421.
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
Dussupt, Vincent, Rajeshwer S. Sankhala, Gregory D. Gromowski-, -Kathryn E. Stephenson-, Gordon Joyce, and Shelly J. Krebs. 2020. “Potent Zika and Dengue Cross-Neutralizing Antibodies Induced by Zika Vaccination in a Dengue-Experienced Donor”. Nature Medicine 26 (2): 228-35.
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
Mayer, Bryan T., Lily Zhang, Allan C. deCamp-, -Michel Nussenzweig, Kathryn E. Stephenson, Boris Julg-, and -Huub C. Gelderblom. 2024. “Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV”. Pharmaceutics 16.
Live-attenuated Chikungunya vaccine: a possible new era
Stephenson, Kathryn E. 2023. “Live-Attenuated Chikungunya Vaccine: A Possible New Era”. Lancet 401 (10394): 2090-91.
Novel chikungunya vaccine shows promise for durable protection
Stephenson, Kathryn E. 2022. “Novel Chikungunya Vaccine Shows Promise for Durable Protection”. Lancet Infectious Diseases 22 (9): 1259-61.
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters
Tostanoski, Lisa H., Abishek Chandrashekar, Shivani Patel-, -Kathryn E. Stephenson-, -Hanneke Schuitemaker, and Dan H. Barouch. 2022. “Passive Transfer of Ad26.COV2.S-Elicited IgG from Humans Attenuates SARS-CoV-2 Disease in Hamsters”. NPJ Vaccines 7 (1): 2.